Loading the security overview…
Where the tokens are
$10,936.14*in 2 tokens
Details…
- NVOonOndo · ETH292.801571$10,936.14*
- NVOxxStocks · SOL0.000019$0.00
No venues yet
No vault or pool we index takes these tokens.
Where the tokens are
Key statistics
technicals as of Oct 1, 2026- Market cap
- $209.99B
- P/E
- —
- 52-week range
- $35.12 – $64.16price at 8% of range
- Volume
- 9.49M
- Previous close
- $37.40
- P/S
- —
- P/B
- —
- Dividend yield
- —$1.16 a year
- Next ex-dividend
- —
- Next earnings
- Nov 4before the open
- Beta
- -0.2390 days, against SPY
- RSI (14)
- 27.2as of Oct 1
Figures describe Novo Nordisk shares, not any token.
Every tokenized version
Search and filter all tokensEach row is one issuer’s token for Novo Nordisk, with the chains it is deployed on. A bold chain is one where these wallets hold a balance. Tokens are not shares: no issuer in the registry publishes a shares-per-token ratio, so a balance is counted one per share and marked where that assumption is doing work.
About Novo-Nordisk A/S
novonordisk.comWith roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
- Type
- American depositary receipt
- Sector
- Healthcare › Pharmaceuticals
- Exchange
- NYSE
- Listed since
- Apr 30, 1981
- Shares outstanding
- 3.39B
- Employees
- 69,500
Themes
Biotech - Drug Development › Metabolic & CardiometabolicLongevity & Aging › Age-Related Therapeutics
Companies sharing these themesAs the market data provider names it. Where that differs from the issuers’ name for the security, both are shown so the difference is visible.
